Bodygrowth Novel Peptide 98%+ Mots-C (human) P21 Peptides CAS: 1627580-64-6

Model NO.
1627580-64-6
Trademark
inno
Origin
China
HS Code
2601111000
Production Capacity
10000
Reference Price
$ 54.00 - 90.00

Product Description

Bodygrowth Novel Peptide 98%+ Mots-C (human) P21 Peptides CAS: 1627580-64-6
Bodygrowth Novel Peptide 98%+ Mots-C (human) P21 Peptides CAS: 1627580-64-6

Name: P21 Peptide
Sequence: Ac-DGGL(A)G-NH2
Molecular formula: C30H54N6O5
Molecular weight : 579.3
Purity: >95.0%
Source: syntheti
Purity:98%
Source: synthetic
Appearance: White Powder
Minimum Order Quantity: 1 g
Brand Name: Yinherb
Test Method: HPLC
Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below-18° C.What is Acetyl

What is Peptide 6C / P21 Peptide?
Researchers found that the main neurogenic and memory enhancing effects from Cerebrolysin were due to its ability to react to human CNTF. So the researchers narrowed their search, and found that an 11-mer peptide, labeled peptide 6 (Ac-VGDGGLFEKKL-NH2), enhanced hippocampus-dependent learning and memory, increased neurogenesis, and neuronal plasticity. They then determined the most active sub-sequence in the peptide called peptide 6C (Ac-DGGL-NH2). However, this peptide sequence showed to have poor blood brain barrier permeability, and was easily broken down by plasma enzymes. To combat this, they added an adamantane moiety to the N-terminus of the peptide sequence. This highly lipophilic tricyclic alkane greatly increased the BBB permeability, and protected the peptide from enzymatic degredation. 


One of the signs of aging is the gradual loss of cell function. In turn, this inhibits the working tissue of organs and leads to less physical ability. As a result, aging is the leading risk for chronic disease.

We link aging with reduced MOTS-c levels in many tissues, including skeletal muscle and circulation.

According to study results, MOTS-c treatment helped middle-aged and old mice run significantly longer and further than untreated mice. What's more, old mice outperformed untreated middle-aged mice. The results suggest physical re-programming rather than just rejuvenation. In other words, MOTS-c seems to increase exercise ability on a cellular level.

 

 

PNEUTEC.IT, 2023